KAZIA THERAPEUTICS-SPON ADR (KZIA)
US48669G1058 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.09K -99.99% | 22.56K 979.43% | 2.32M 10,183.69% | 22.5M 869.83% | 2.888M -87.16% | 25.825M 794.22% | 63.552M 146.09% | 90.1M 41.77% | 110.59M 22.74% | |
| EBITDA YoY % growth | N/A -1,735.97% | N/A -9.90% | N/A 124.14% | 7.2M 16.50% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -25.382M -300.46% | -24.125M 4.95% | -27.193M -12.72% | 5.16M 118.98% | -18.554M -459.57% | -1.374M 92.59% | 27.763M 2,120.02% | 47.228M 70.11% | 61.386M 29.98% | |
| Operating Margin | -1,214,456.46% | -106,934.97% | -1,172.11% | 22.93% | -642.44% | -5.32% | 43.69% | 52.42% | 55.51% | |
| EPS YoY % growth | N/A -8,174.48% | N/A 89.43% | N/A 101.00% | 0.01 27.27% | -0.50 -3,608.73% | 0.00 100.00% | 0.70 | 1.20 71.37% | 1.60 33.33% |
All data in AUD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in AUD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -1.90 -118.14% | -0.51 | -1.39 | -272.55% |
| Q4 2022 Q2Q % growth | -0.87 | -0.10 | -0.77 | -753.92% |
| Q2 2021 Q2Q % growth | -22.22% | -0.16 | % | |
| Q2 2020 Q2Q % growth | 49.80% | -0.13 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 6.45K 4,507.14% | % | ||
| Q4 2023 Q2Q % growth | 22.42K -100.00% | 23.46K | -23.46K | -100.00% |
| Q2 2023 Q2Q % growth | 140 -92.96% | % | ||
| Q4 2022 Q2Q % growth | 110 -100.00% | 518.16K | -518.05K | -99.98% |
| Q2 2022 Q2Q % growth | 1.99K -93.54% | % | ||
| Q4 2021 Q2Q % growth | 15.194M 45,473.28% | % | ||
| Q2 2021 Q2Q % growth | 30.82K -5.34% | 1.522M | -1.492M | -97.98% |
| Q4 2020 Q2Q % growth | 33.34K -66.53% | % | ||
| Q2 2020 Q2Q % growth | 32.56K 12.94% | 1.522M | -1.49M | -97.86% |
| Q2 2019 Q2Q % growth | 28.83K | 3.12M | -3.091M | -99.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |